303 related articles for article (PubMed ID: 12537033)
1. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
Verdoux H; Gindre C; Sorbara F; Tournier M; Swendsen JD
Psychol Med; 2003 Jan; 33(1):23-32. PubMed ID: 12537033
[TBL] [Abstract][Full Text] [Related]
2. Psychosis reactivity to cannabis use in daily life: an experience sampling study.
Henquet C; van Os J; Kuepper R; Delespaul P; Smits M; Campo JA; Myin-Germeys I
Br J Psychiatry; 2010 Jun; 196(6):447-53. PubMed ID: 20513854
[TBL] [Abstract][Full Text] [Related]
3. Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study.
Kuepper R; van Os J; Lieb R; Wittchen HU; Henquet C
Psychol Med; 2011 Oct; 41(10):2121-9. PubMed ID: 21466750
[TBL] [Abstract][Full Text] [Related]
4. Is psychotic disorder associated with increased levels of craving for cannabis? An Experience Sampling study.
Kuepper R; Oorschot M; Myin-Germeys I; Smits M; van Os J; Henquet C
Acta Psychiatr Scand; 2013 Dec; 128(6):448-56. PubMed ID: 23330571
[TBL] [Abstract][Full Text] [Related]
5. Social environments and daily life occurrence of psychotic symptoms--an experience sampling test in a non-clinical population.
Verdoux H; Husky M; Tournier M; Sorbara F; Swendsen JD
Soc Psychiatry Psychiatr Epidemiol; 2003 Nov; 38(11):654-61. PubMed ID: 14614554
[TBL] [Abstract][Full Text] [Related]
6. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
Hides L; Kavanagh DJ; Dawe S; Young RM
Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
9. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
10. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
[TBL] [Abstract][Full Text] [Related]
11. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use in psychotic patients.
Sembhi S; Lee JW
Aust N Z J Psychiatry; 1999 Aug; 33(4):529-32. PubMed ID: 10483847
[TBL] [Abstract][Full Text] [Related]
13. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls.
Cassidy CM; Lepage M; Harvey PO; Malla A
Schizophr Res; 2012 May; 137(1-3):39-44. PubMed ID: 22436394
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use and risk of psychosis: an etiological link?
Verdoux H; Tournier M
Epidemiol Psichiatr Soc; 2004; 13(2):113-9. PubMed ID: 15298320
[TBL] [Abstract][Full Text] [Related]
16. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population.
Tournier M; Sorbara F; Gindre C; Swendsen JD; Verdoux H
Psychiatry Res; 2003 May; 118(1):1-8. PubMed ID: 12759155
[TBL] [Abstract][Full Text] [Related]
18. [Motivational interviewing for cannabis users with psychotic disorders].
Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use and dimensions of psychosis in a nonclinical population of female subjects.
Verdoux H; Sorbara F; Gindre C; Swendsen JD; van Os J
Schizophr Res; 2003 Jan; 59(1):77-84. PubMed ID: 12413646
[TBL] [Abstract][Full Text] [Related]
20. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
